Expert Opinion on Drug Metabolism & Toxicology, Volume 16, Issue 8 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 16, Issue 8 (2020)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Volume 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

EDITORIAL

Editorial
Soft drugs: design principles, success stories, and future perspectives
Peter Buchwald
Pages: 645-650
Published online: 20 Jun 2020
First Page PreviewforSoft drugs: design principles, success stories, and future perspectives | Full Text | References | PDF (1.3 MB) | EPUB
  • 11141 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Review

In silico models for genotoxicity and drug regulation
Romualdo Benigni, Arianna Bassan & Manuela Pavan
Pages: 651-662
Published online: 28 Jun 2020
AbstractforIn silico models for genotoxicity and drug regulation | Full Text | References | PDF (410.3 KB) | EPUB
  • 434 Views
  • 21 CrossRef citations
  • 0Altmetric
Toxicological considerations in the treatment of axial spondylo-arthritis
Francesca Marino, Salvatore D’Angelo, Ignazio Francesco Masala, Elisabetta Gerratana, Valeria Nucera, Laura La Corte, Manuela Giallanza, Piercarlo Sarzi-Puttini & Fabiola Atzeni
Pages: 663-672
Published online: 27 Jun 2020
AbstractforToxicological considerations in the treatment of axial spondylo-arthritis | Full Text | References | PDF (320.9 KB) | EPUB
  • 157 Views
  • 1 CrossRef citations
  • 0Altmetric
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Pages: 673-701
Published online: 23 Jun 2020
AbstractforPharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease | Full Text | References | PDF (3.7 MB) | EPUB
  • 694 Views
  • 25 CrossRef citations
  • 0Altmetric
New clinical targets of d-chiro-inositol: rationale and potential applications
Antonio Simone Laganà, Simone Garzon & Vittorio Unfer
Pages: 703-710
Published online: 09 Jul 2020
AbstractforNew clinical targets of d-chiro-inositol: rationale and potential applications | Full Text | References | PDF (331.6 KB) | EPUB
  • 221 Views
  • 13 CrossRef citations
  • 0Altmetric
PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches
Jingheng Wang, Monicah Bwayi, Rebecca R. Florke Gee & Taosheng Chen
Pages: 711-722
Published online: 16 Jun 2020
AbstractforPXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches | Full Text | References | PDF (1.3 MB) | EPUB
  • 500 Views
  • 14 CrossRef citations
  • 0Altmetric
An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects
Wan-Chun Chang, Shuen-Iu Hung, Bruce C Carleton & Wen-Hung Chung
Pages: 723-734
Published online: 16 Jul 2020
AbstractforAn update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects | Full Text | References | PDF (848.5 KB) | EPUB
  • 500 Views
  • 9 CrossRef citations
  • 0Altmetric

Original Research

Article
Effect of clarithromycin pre-treatment on the pharmacokinetics of metoclopramide after their simultaneous oral intake
Iram Kaukab, Syed Nisar Hussain Shah, Zelal Jaber Kharaba, Manal Ali Buabeid, Yaseen Abd Alfoteih & Ghulam Murtaza
Pages: 735-740
Published online: 14 Aug 2020
AbstractforEffect of clarithromycin pre-treatment on the pharmacokinetics of metoclopramide after their simultaneous oral intake | Full Text | References | PDF (360 KB) | EPUB
  • 229 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications
Gianluca D’Onofrio et al.
Editorial | Published online: 31 May 2024
Free Access
Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol
Anne Kasten et al.
Review Article | Published online: 29 May 2024
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Nguyen Quoc Khanh Le et al.
Review Article | Published online: 27 May 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperoni et al.
Review Article | Published online: 22 May 2024
Open Access
View all latest articles